Nancy C. Andrews, M.D., Ph.D., has been Dean of the School of Medicine and Vice Chancellor for Academic Affairs at Duke University since 2007. She is also the Nanaline H. Duke Professor of Pediatrics and Professor of Pharmacology & Cancer Biology.
Dr. Andrews received her B.S. and M.S. degrees in Molecular Biophysics and Biochemistry from Yale University. As a student in the Medical Scientist Training Program she received her M.D. from Harvard Medical School and her Ph.D. in Biology from M.I.T. She did her internship and residency training in Pediatrics at Children’s Hospital Boston and fellowship in Pediatric Hematology/Oncology at Children’s Hospital and Dana-Farber Cancer Institute.
Dr. Andrews joined the faculty of Harvard Medical School in 1993, in the Departments of Pediatrics at Children’s Hospital and Pediatric Oncology at Dana-Farber. She also became an investigator of the Howard Hughes Medical Institute, a position she held until 2006. She rose through the academic ranks at Harvard, directing a research laboratory, serving as an attending physician on the general pediatrics, oncology and hematology clinical services and teaching medical and graduate students. Her research, continuously funded by the National Institutes of Health (NIH) since 1993, has led to important advances in understanding mammalian iron biology and human iron diseases, and she is recognized as an international leader in her field. In 2003 she became the Leland Fikes Professor of Pediatrics at Harvard.
Between 1999 and 2003 Dr. Andrews was Director of the Harvard-M.I.T. M.D./Ph.D. Program, and the principal investigator of its MSTP grant. From 2003 to 2007 she served as Dean for Basic Sciences and Graduate Studies at Harvard Medical School, before being recruited to Duke in 2007 for her current role. Dr. Andrews has received many awards for her scholarship, mentorship and leadership. She has been elected to membership in honorific organizations including the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine of the National Academies and the American Academy of Arts and Sciences, and she is a Fellow of the American Association for the Advancement of Science. Her major national leadership roles have included serving on the Council of the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH, as President of the American Society for Clinical Investigation, on the Board of Directors of the Burroughs Wellcome Fund, on the governing Council of the Institute of Medicine of the National Academies, on the Board of Directors of the American Academy of Arts and Sciences and on the Scientific Management Review Board of the NIH. She is also a member of the Board of Directors of Novartis AG. She was profiled in Newsweek as one of 10 notable women leaders in 2008 and in Working Mother as one of the 10 Most Powerful Moms in Health Care in 2010.